Last reviewed · How we verify
NCT06732297: SFAT
Stronger Families Through Art Therapy: A Mixed Methods Programme Evaluation Study
NA trial testing dyadic art therapy intervention for parent-child relationship in vulnerable families in Vulnerable Families in 96 participants. Currently enrolling.
1 July 2026
Quick facts
| Lead sponsor | Nanyang Technological University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 96 |
| Start date | 22 February 2025 |
| Primary completion | 1 July 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- dyadic art therapy intervention for parent-child relationship in vulnerable families
Conditions studied
- Vulnerable Families — all drugs for Vulnerable Families →
Sponsor
Nanyang Technological University
Who can join
Adults 7 to 99, any sex, with Vulnerable Families. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current research aims to evaluate the effectiveness and feasibility of the Strong Families Through Art Therapy (SFAT) programme, which was developed to improve the parent-child relationship in vulnerable families. The main questions it aims to answer are: 1. Is the programme effective in enhancing quality of life and family resilience among parents? 2. Is the programme effective in enhancing quality of life among children? 3. Is the programme feasible and acceptable for large scale implementation in Singapore? Researchers will compare the status of family participants (caregivers and children) before and after they take the programme and compare family participants who take the programme with family participants who have not yet taken the programme to see if the programme is effective in benefiting the participants. Researchers will also invite family participants to discuss about the programme. Family participants will 1. Take the 10-week SFAT programme 2. Complete assessment survey for 3 times 3. Attend a focus group discussion (optional) To assess the programme feasibility, researchers will additional invite art therapist participants to evaluate the programme and invite community staff participants to discuss about the programme implementation. Art therapist participants will complete programme and session evaluation reports. Community staff participants will attend a focus group discussion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06732297
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vulnerable Families
Currently open trials in the same condition.
- NCT07162493 — ATTACH in Denmark: A Feasibility Randomized Controlled Trial · NA · recruiting
Other Nanyang Technological University trials
Trials by the same sponsor.
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07497711 — Virtual Menstrual Pain Approaches in Females · Phase 2, PHASE3 · not yet recruiting
- NCT07288892 — Effects of Pulsed Electromagnetic Field Therapy on Sport Performance and Recovery · NA · recruiting
- NCT06991764 — Investigating the Effectiveness of a 2-week Novel Non-invasive Brain Stimulation Technique on Cognitive Outcomes in Heal · NA · not yet recruiting
- NCT06609200 — Electro-Acupuncture for Obese Patients With Insulin Resistance · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06732297 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nanyang Technological University
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06732297.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing